News & Events

• April 15, 2019
  

  Muscular Dystrophy Association 2019 Clinical and Scientific Conference

  Jane Larkindale, Executive Director of D-RSC, attended the Muscular Dystrophy Association Clinical and Scientific Conference in Orlando, FL on April 14- April 16. She presented two posters: Development of a Clinical Trial Simulation Tool for Duchenne Muscular Dystrophy Through the Duchenne Regulatory Science Consortium Value of Skeletal Muscle Damage Biomarkers as Pharmacodynamic Biomarkers for Neuromuscular......
• June 28, 2018
  

  Parent Project Muscular Dystrophy (PPMD) 2018 Annual Conference

  Jane Larkindale, Executive Director of D-RSC, attended the Parent Project Muscular Dystrophy (PPMD) 2018 Annual Conference in Scottsdale, AZ on June 28 – July 1.  She participated on a panel, Today’s Tomorrow: Looking at the Future and presented two posters: Accelerating drug development: data sharing and developing quantitative tools through the Duchenne Regulatory Science Consortium (D-RSC)......
• March 11, 2018
  

  D-RSC and PSTC presented “Biomarkers for Muscle Diseases” poster at the 2018 MDA Clinical Conference

• March 11, 2018
  

  D-RSC presents poster on advancing drug development for Duchenne through data sharing and quantitative tool development at the 2018 MDA Clinical Conference

• June 30, 2017
  

  D-RSC presents poster and talks about data standards at the Duchenne Connect Conference